Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
Filed Jun 16, 2015 · 10-K · 77 days after period end · 0001019687-15-002432
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $3.98M | $2.91M | $2.71M |
| Net Income | -$1.50M | $7.46M | -$1.69M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed Jun 16, 2015 · 77 d after period end